FDA Brief

Company record

Meridian Bioscience, Inc

1 FDA warning letter since 2023 and 3 recalls in the last 12 months.

Get an email the day FDA posts anything new about Meridian Bioscience, Inc.

Warning letters

  1. Meridian Bioscience, Inc

    FDA warns Meridian Bioscience's Magellan Diagnostics over quality system failures and unreported problems with its blood lead test kits.

    High risk

Recalls

ReportedClassFirmProduct and reason
Jan 14 Class II Meridian Bioscience Inc
Device
Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300
The affected lots show a decline in performance over time, which may lead to false-negative results.
Nov 26, 2025 Class II Meridian Bioscience Inc
Device
Meridian Bioscience, alethia c. Difficile, Catalog Number 480050, Nucleic Acid Amplification Test Assay
The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume.
Nov 26, 2025 Class II Meridian Bioscience Inc
Device
Meridian Bioscience, Group B Streptococcus, Catalog Number 480050, Nucleic Acid Amplification Test Assay
The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume.